American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 16–20 Feb 2018

被引:0
作者
Kathy A. Fraser
机构
[1] Adis Publications,
来源
American Journal of Clinical Dermatology | 2018年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:287 / 290
页数:3
相关论文
共 52 条
[1]  
Ruzicka T(2017)Anti-interleukin-31 receptor A antibody for atopic dermatitis N Engl J Med. 376 826-835
[2]  
Hanifin JM(2016)Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial Br J Dermatol. 175 902-911
[3]  
Furue M(2015)Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate J Am Acad Dermatol. 73 395-399
[4]  
Bissonnette R(2018)Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study J Am Acad Dermatol. 137 2497-2504
[5]  
Papp KA(2017)Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy J Invest Dermatol. 359 97-103
[6]  
Poulin Y(2017)Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis Sci Transl Med. 13 e107-107
[7]  
Levy LL(2018)Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients Science. 31 91-773
[8]  
Urban J(2017)Hair growth in two alopecia patients after fecal microbiota transplant ACG Case Rep J. 68 765-133
[9]  
King BA(2014)Practical eminence and experience-based recommendations for use of TNF-α inhibitors in sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis. 74 127-217
[10]  
Guttman-Yassky E(2013)A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis J Am Acad Dermatol. 62 205-846